"At AnMed Health Cancer Center, state-of-the-art technology and expert outpatient care are combined to provide nationally-recognized treatment. The Cancer Center offers a range of diagnostic and treatment services, including radiation therapy, infusion, chemotherapy and 3D mammography."

During the past decade, AnMed Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 51 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AnMed Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 37 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AnMed Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "AnMed Cancer Center" are "Breast Cancer" (21 trials), "Lung Cancer" (13 trials), "Lymphoma" (12 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (8 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "AnMed Cancer Center" in a lesser frequency.

Most popular intervention types in "AnMed Cancer Center" are "Drug" (66 trials), "Other" (29 trials), "Biological" (21 trials), "Radiation" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (18 trials), "radiation therapy" (11 trials), "cyclophosphamide" (10 trials), "gemcitabine hydrochloride" (7 trials) and "prednisone" (7 trials). Other intervention names were less common.

The vast majority of trials in "AnMed Cancer Center" are 66 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "AnMed Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in AnMed Cancer Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in AnMed Cancer Center, 1 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".